Skip to content
KTKetamine Troche

Rapid-Acting Therapeutics

Articles tagged with “Rapid-Acting Therapeutics”

1 article
BXCL501 Enters Phase 2a for Acute Stress and PTSD Prevention visual guide

BXCL501 Enters Phase 2a for Acute Stress and PTSD Prevention

BioXcel's sublingual dexmedetomidine enters a DoD-backed Phase 2a trial for acute stress reactions — what it means for the trauma treatment landscape.

Read
Back to all articles

Contact Ketamine Troche

Send corrections, provider questions, or advertising inquiries.

Contact the site